Chosa ApS: Financial statements 2024
CVR: 43134477
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Chosa ApS (CVR 43134477) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -1,130,610 and a net result of DKK -3,586,839 compared with DKK -2,069,955 the year before. Equity in the 2024 report amounted to DKK 7,484,752. The solvency ratio was 66.9%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -1,130,610
- Profit/Loss
- DKK -3,586,839
- Equity
- DKK 7,484,752
- Total Assets
- DKK 11,189,475
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -1.1 mio. | -3.6 mio. | 7.5 mio. | 1 |
| 2023 | - | -1.5 mio. | -2.1 mio. | 9 mio. | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Chosa ApS has published its annual report for 2023. Gross profit came to DKK -1,542,553, and the net result was DKK -2,069,955.
About Chosa ApS
Chosa ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2022. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Peter Buhl and Claus Frisenberg Pedersen. The company is owned by Chosa Oncology AB. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -2,136,143 and a net result of DKK -2,632,024 compared with DKK -3,586,839 the year before. Equity in the 2025 report amounted to DKK 5,175,030.